Literature DB >> 25362835

Characterization of an oncolytic herpes simplex virus drug candidate.

Ozan S Kumru1, Sangeeta B Joshi, Prem Thapa, Nigel Pheasey, Paul S Bullock, Houman Bashiri, Christine S Siska, Bruce A Kerwin, Feng He, David B Volkin, C Russell Middaugh.   

Abstract

The structural integrity and conformational stability of a genetically modified live, oncolytic herpes simplex virus (o-HSV) were investigated across a wide pH (5.5-8.0) and temperature (10°C-87.5°C) range. A combination of circular dichroism, intrinsic and extrinsic fluorescence, and static light scattering results was visualized using an empirical phase diagram approach to provide a global assessment of physical stability. Distinct phases were identified including the native state of the virus, an intermediate phase that could represent gradual swelling and/or shedding of the viral envelope, and a highly disrupted, aggregated phase. The nature of these altered forms of the virus was further evaluated by transmission electron microscopy and viral plaque assays. The effect of freeze-thaw (F/T) stress on o-HSV was also examined. After one F/T cycle, a loss of infectious virus titers was observed. In addition, the monomeric virus particle concentration decreased during F/T stress, whereas there was a concurrent increase in larger particles (2-10 μm). The comprehensive biophysical characterization of viral stability conducted in this study identified major degradation events leading to loss of infectivity of o-HSV and represents an important step toward stabilization of the virus against thermal and F/T stresses.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  biotechnology; cancer; formulation; particle size; phase diagram; physical stability; preformulation; viral vectors

Mesh:

Year:  2014        PMID: 25362835     DOI: 10.1002/jps.24211

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.

Authors:  U Kumar; S Kumar
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

2.  Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.

Authors:  Sanjeev Agarwal; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534

3.  Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.

Authors:  Ozan S Kumru; Soraia Saleh-Birdjandi; Lorena R Antunez; Eddy Sayeed; David Robinson; Sjoerd van den Worm; Geoffrey S Diemer; Wilma Perez; Patrizia Caposio; Klaus Früh; Sangeeta B Joshi; David B Volkin
Journal:  Vaccine       Date:  2019-09-20       Impact factor: 3.641

Review 4.  Viral Infections in Burn Patients: A State-Of-The-Art Review.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Grzegorz Buszewicz; Alicja Forma; Monika Sitarz; Grzegorz Teresiński
Journal:  Viruses       Date:  2020-11-17       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.